Fund Holdings — Sio Capital Management, LLC

Total Portfolio Value:
$287.15M
Total Bought:
$119.12M
Total Sold:
$234.03M
Net Transaction:
-$114.91M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Laboratory Corporation Of America Holdings165,123225,902+60,779$37.53M$49.35M17.19%+$11.82M
The Cigna Group(CI)116,55376,086-40,467$34.90M$27.63M9.62%-$7.27M
Globus Medical, Inc.CL A(GMED)532,089393,420-138,669$28.36M$21.10M7.35%-$7.25M
Madrigal Pharmaceuticals, Inc.(MDGL)051,000+51,000$0$13.62M4.74%+$13.62M
GSK plcADR(GSK)571,391263,445-307,946$21.18M$11.29M3.93%-$9.88M
Zimmer Biomet Holdings, Inc.(ZBH)72,30074,179+1,879$8.80M$9.79M3.41%+$991.2K
Medtronic plcSHS(MDT)0105,000+105,000$0$9.15M3.19%+$9.15M
Organon & Co.(OGN)0479,023+479,023$0$9.01M3.14%+$9.01M
Tyra Biosciences, Inc.(TYRA)0535,741+535,741$0$8.79M3.06%+$8.79M
Embecta Corp.(EMBC)736,008585,418-150,590$13.93M$7.77M2.71%-$6.16M
Teleflex Incorporated(TFX)36,52733,878-2,649$9.11M$7.66M2.67%-$1.45M
Arcutis Biotherapeutics, Inc.(ARQT)635,969635,9690$2.05M$6.30M2.19%+$4.25M
BridgeBio Pharma, Inc.(BBIO)131,753203,174+71,421$5.32M$6.28M2.19%+$963.3K
Humacyte, Inc.(HUMA)02,000,000+2,000,000$0$6.22M2.17%+$6.22M
ANI Pharmaceuticals, Inc.(ANIP)087,354+87,354$0$6.04M2.10%+$6.04M
Astria Therapeutics Inc0410,267+410,267$0$5.77M2.01%+$5.77M
ARS Pharmaceuticals, Inc.(SPRY)1,105,911536,163-569,748$6.06M$5.48M1.91%-$580.8K
Healthcare Services Group, Inc.(HCSG)810,307421,317-388,990$8.40M$5.26M1.83%-$3.14M
Apogee Therapeutics Inc078,000+78,000$0$5.18M1.81%+$5.18M
Fusion Pharmaceuticals Inc246,036243,035-3,001$2.36M$5.18M1.80%+$2.82M
Erasca, Inc.(ERAS)02,427,184+2,427,184$0$5.00M1.74%+$5.00M
X4 Pharmaceuticals, Inc.(XFOR)3,588,4273,588,4270$3.01M$4.99M1.74%+$1.98M
Nuvation Bio Inc.CL A(NUVB)01,336,231+1,336,231$0$4.86M1.69%+$4.86M
Scholar Rock Holding Corporation(SRRK)0273,720+273,720$0$4.86M1.69%+$4.86M
Integra LifeSciences Holdings Corporation(IART)0137,000+137,000$0$4.86M1.69%+$4.86M
Ocular Therapeutix, Inc.(OCUL)971,446383,026-588,420$4.33M$3.49M1.21%-$847.1K
CytomX Therapeutics, Inc.(CTMX)01,598,590+1,598,590$0$3.48M1.21%+$3.48M
Enanta Pharmaceuticals, Inc.(ENTA)0177,004+177,004$0$3.09M1.08%+$3.09M
Stoke Therapeutics, Inc.(STOK)0225,496+225,496$0$3.04M1.06%+$3.04M
Modular Medical Inc689,3521,539,352+850,000$1.25M$2.85M0.99%+$1.59M
Rapt Therapeutics Inc0315,000+315,000$0$2.83M0.99%+$2.83M
Revance Therapeutics Inc0468,871+468,871$0$2.31M0.80%+$2.31M
Ventyx Biosciences Inc0378,000+378,000$0$2.08M0.72%+$2.08M
Boundless Bio, Inc.(BOLD)0143,000+143,000$0$2.04M0.71%+$2.04M
Aprea Therapeutics, Inc.(APRE)280,000276,603-3,397$1.32M$1.85M0.64%+$534.5K
Third Harmonic Bio Inc163,363163,3630$1.79M$1.54M0.54%-$249.9K
Prelude Therapeutics Incorporated(PRLD)320,394320,3940$1.37M$1.52M0.53%+$150.6K
IDEAYA Biosciences, Inc.(IDYA)33,00733,0070$1.17M$1.45M0.50%+$274.0K
Ironwood Pharmaceuticals, Inc.CL A(IRWD)0149,400+149,400$0$1.30M0.45%+$1.30M
Foghorn Therapeutics Inc.(FHTX)121,672121,6720$784.8K$816.4K0.28%+$31.6K
Nyxoah SaSHS
SHS
200,07650,839-149,237$928.4K$685.8K0.24%-$242.5K
Vincerx Pharma Inc102,049102,0490$120.4K$516.4K0.18%+$395.9K
Nextcure Inc130,000130,0000$148.2K$289.9K0.10%+$141.7K
Avalo Therapeutics, Inc.(AVTX)010,151+10,151$0$220.8K0.08%+$220.8K
Aslan Pharmaceuticals LtdADS254,150254,1500$132.7K$156.4K0.05%+$23.7K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)400,000400,0000$172.0K$109.9K0.04%-$62.1K
Humacyte, Inc.W EXP 08 27 202(HUMA)49,99849,9980$21.6K$31.0K0.01%+$9.4K
Caremax IncW EXP 06 08 20212,80812,8080$175$3020.00%+$127
Caremax IncCL A30,7410-30,741$15.3K$0—-$15.3K
COMPASS Pathways plcADS(CMPS)251,5320-251,532$2.20M$0—-$2.20M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)150,0000-150,000$906.0K$0—-$906.0K
Gracell Biotechnologies IncADS5,001,5800-5,001,580$50.22M$0—-$50.22M
Harpoon Therapeutics Inc297,9360-297,936$3.39M$0—-$3.39M
Immunogen Inc644,3660-644,366$19.11M$0—-$19.11M
Inogen, Inc.(INGN)52,7940-52,794$289.8K$0—-$289.8K
Merrimack Pharmaceuticals In288,4660-288,466$3.87M$0—-$3.87M
Mirati Therapeutics Inc1,451,9250-1,451,925$85.30M$0—-$85.30M
Protagonist Therapeutics Inc460,0440-460,044$10.55M$0—-$10.55M
United Therapeutics Corporation(UTHR)80,0500-80,050$17.60M$0—-$17.60M
Vanda Pharmaceuticals Inc.(VNDA)97,6160-97,616$411.9K$0—-$411.9K
Page 1 of 1
Sio Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail